These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 27486728

  • 21. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
    Rishi P, Sharma T, Koundanya V, Bansal N, Saravanan M, Ravikumar R, Ramamurthy S.
    Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
    [Abstract] [Full Text] [Related]

  • 22. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A, Kao LY, Liu L, Wang NK.
    BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871
    [Abstract] [Full Text] [Related]

  • 23. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Leahey A, Griffin G, Jabbour P, Shields JA.
    Retina; 2013 Mar 15; 33(10):2103-9. PubMed ID: 23873161
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç İ, Varan A, Akyüz C.
    Eur J Ophthalmol; 2017 Jun 26; 27(4):423-427. PubMed ID: 28106239
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Dec 26; 64(12):. PubMed ID: 28646513
    [Abstract] [Full Text] [Related]

  • 26. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY.
    Jpn J Ophthalmol; 2015 Mar 26; 59(2):109-17. PubMed ID: 25465196
    [Abstract] [Full Text] [Related]

  • 27. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
    Stacey AW, De Francesco S, Borri M, Hadjistilianou T.
    Ophthalmol Retina; 2021 Aug 26; 5(8):824-830. PubMed ID: 33221516
    [Abstract] [Full Text] [Related]

  • 28. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug 26; 96(8):1078-83. PubMed ID: 22694968
    [Abstract] [Full Text] [Related]

  • 29. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
    Francis JH, Iyer S, Gobin YP, Brodie SE, Abramson DH.
    Ophthalmology; 2017 Oct 26; 124(10):1548-1555. PubMed ID: 28545735
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH.
    Ophthalmology; 2017 Apr 26; 124(4):488-495. PubMed ID: 28089679
    [Abstract] [Full Text] [Related]

  • 31. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
    Riazi-Esfahani H, Masoomian B, Khodabandeh A, Amini A, Taghizadeh S, Boujabadi L, Sharifkashani S, Shields CL, Ghassemi F.
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr 26; 261(4):1167-1175. PubMed ID: 36401651
    [Abstract] [Full Text] [Related]

  • 32. Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
    Kotlyar B, Shapiro M, Blair M.
    Ophthalmic Surg Lasers Imaging Retina; 2019 Apr 01; 50(4):248-252. PubMed ID: 30998248
    [Abstract] [Full Text] [Related]

  • 33. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH, Catalanotti F, Brodie SE, Kellick MG, Francis JH.
    Ophthalmic Genet; 2018 Jun 01; 39(3):353-356. PubMed ID: 29513055
    [Abstract] [Full Text] [Related]

  • 34. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
    Stathopoulos C, Gaillard MC, Moulin A, Puccinelli F, Beck-Popovic M, Munier FL.
    Retina; 2019 Dec 01; 39(12):2273-2282. PubMed ID: 30312257
    [Abstract] [Full Text] [Related]

  • 35. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M, Rao R, Mulay K, Reddy VAP, Honavar SG.
    Ophthalmology; 2024 Oct 01; 131(10):1215-1224. PubMed ID: 38703794
    [Abstract] [Full Text] [Related]

  • 36. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F, Amoli FA.
    Int Ophthalmol; 2014 Jun 01; 34(3):533-40. PubMed ID: 24043335
    [Abstract] [Full Text] [Related]

  • 37. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
    Tuncer S, Sencer S, Kebudi R, Tanyıldız B, Cebeci Z, Aydın K.
    Acta Ophthalmol; 2016 Nov 01; 94(7):e644-e651. PubMed ID: 27214798
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.
    Ophthalmology; 2012 Mar 01; 119(3):611-6. PubMed ID: 22197434
    [Abstract] [Full Text] [Related]

  • 39. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL.
    Arch Ophthalmol; 2012 Oct 01; 130(10):1268-71. PubMed ID: 23044940
    [Abstract] [Full Text] [Related]

  • 40. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.
    Pediatr Blood Cancer; 2013 May 01; 60(5):766-70. PubMed ID: 23024125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.